Home / Companies / Inozyme Pharma, Inc. / 18 Jun 2024
Inozyme Pharma, Inc.: meeting of 18 Jun 2024
Votes reported on Form N-PX, item by item
62 Form N-PX filers reported votes at the Inozyme Pharma, Inc. meeting of 18 Jun 2024. Their records fall into 2 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
3 nominees; 59.0% of reported votes for; 59 filers withheld from or voted against at least one nominee.
327 vote records from 62 filers. 7 of the 60 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
109 vote records from 62 filers. 1 of the 60 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
How the largest families voted
| Family | 1. Directors | 2. Auditor |
|---|---|---|
| Vanguard | For | For |
| BlackRock and iShares | For | For |
| Fidelity | For | For |
| Dimensional | Abstain or withhold * | For |
| State Street and SPDR | Abstain or withhold * | For |
| American Century | For | For |
| Equitable | For | For |
| Charles Schwab | For | For |
| Nuveen and TIAA | For | For |
| ProShares and ProFunds | For | For |
| John Hancock and Manulife | For | For |
| Morgan Stanley, Eaton Vance and Calvert | For | For |
| Goldman Sachs | For | For |
| T. Rowe Price | For | For |
| Lincoln Financial | Abstain or withhold * | For |
| Voya | For | For |
| Nationwide | For | For |
| Victory Capital | For | For |
| Brighthouse Funds | For | For |
| Guggenheim and Rydex | For | For |
| Principal | For | For |
| Pacific Life funds | For | For |
| Global X | For | For |
| DWS | For | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Inozyme Pharma, Inc. meeting?
62 Form N-PX filers reported votes at the meeting of 18 Jun 2024. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Inozyme Pharma, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Inozyme Pharma, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Inozyme Pharma, Inc. with a meeting date within three days of 18 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.